Skip to main content
SpringerLink
Log in

Epidemiology of HIV Infection in Communities of Color in the United States

  • Chapter
  • First Online:
HIV in US Communities of Color

Abstract

Despite significant advancements in human immunodeficiency virus (HIV) care and treatment, racial/ethnic disparities in HIV incidence persist with blacks, persons of mixed-race, and Latinos being disproportionately affected. The intersection of social determinants of health and stigma continue to contribute to the marginalization of vulnerable groups particularly in the South, among rural communities, sexual and gender minorities, and people who inject drugs. This chapter provides a broad overview of the of HIV epidemic in the United States and focuses in detail on each step of the HIV care continuum by describing key populations affected, barriers, and facilitators to reaching each step of the continuum of care (i.e., linkage, retention in HIV care and viral suppression) and describes interventions that have been shown to have a positive impact on the continuum of care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Scandlyn J. When AIDS became a chronic disease. West J Med. 2000;172(2):130–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Arnold EA, Rebchook GM, Kegeles SM. ‘Triply cursed’: racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young black gay men. Cult Health Sex. 2014;16(6):710–22. https://doi.org/10.1080/13691058.2014.905706.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28(3):128–35.

    PubMed  PubMed Central  Google Scholar 

  4. Branson BM, Handsfield HH, Lampe MA, Janssen RS, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR14):1–17. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm.

    PubMed  Google Scholar 

  5. Branson BM, Ibid. 2006.

    Google Scholar 

  6. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446–53.

    PubMed  Google Scholar 

  7. Beckwith CG, Flanigan TP, del Rio C, et al. It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis. 2005;40:1037–40.

    PubMed  Google Scholar 

  8. Bozzette SA. Routine screening for HIV infection---timely and cost-effective. N Engl J Med. 2005;352:620–1.

    CAS  PubMed  Google Scholar 

  9. Schneider E, Whitemore S, Glynn MK, Dominguez K, et al. Surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years – United States, 2008. MMWR. 2008;57(RR10):1–8. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5710a1.htm.

    PubMed  Google Scholar 

  10. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2015. HIV Surveillance Supplemental Report. 2018;23(1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published March 2018. Accessed 10-16-2018.

  11. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016. Centers for Disease Control and Prevention. HIV Surveillance Report. 2016; vol. 28. http://wwwcdcgov/hiv/library/reports/hiv-surveillancehtml Published November 2017. Last accessed 12 Sept 2018.

  12. Ivy W, Ngwangwu-Ike N, Paz-Bailey G. Reductions in HIV diagnoses among African American women: a search for explanations. J Acquir Immune Defic Syndr. 2017;75(Suppl 3):S253–60.

    PubMed  Google Scholar 

  13. Cheong C, Tucker JA, Chandler SD. Reasons for accepting and declining free HIV testing and counseling among young African American women living in disadvantaged southern urban communities. AIDS Patient Care STDs. https://doi.org/10.1089/apc.2018.0090.

  14. Cunningham TO, Croft JB, Liu Y, Lu H, et al. Vital signs: racial disparities in age-specific mortality among blacks or African Americans — United States, 1999–2015. MMWR. 2017;66(17):444–56.

    PubMed  PubMed Central  Google Scholar 

  15. el Bcheraoui C, Mokdad AH, Dwyer-Lindgren L, Bertozzi-Villa A, et al. Trends and patterns of differences in infectious disease mortality among US counties, 1980–2014. JAMA. 2018;319(12):1248–60.

    PubMed  PubMed Central  Google Scholar 

  16. Reif SS, Whetten K, Wilson ER, McAllaster C, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 26(3):351–9.

    Google Scholar 

  17. Rosenberg ES, Purcell DW, Grey JA, Hankin-Wei A, et al. Rates of prevalent and new HIV diagnoses by race and ethnicity among men who have sex with men, U.S. states, 2013–2014. Ann Epidemiol. 2018; https://doi.org/10.1016/j.annepidem.2018.04.008.

  18. Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs — 20 cities, United States, 2015. MMWR. 2018;67(1):23–8.

    PubMed  PubMed Central  Google Scholar 

  19. Conrad C, Bradley HM, Broz D, Buddha W, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone — Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(16):443–4.

    PubMed  PubMed Central  Google Scholar 

  20. Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323–31.

    PubMed  PubMed Central  Google Scholar 

  21. Seth P, Walker T, Hollis N, Figueroa A, Belcher L. HIV testing and service delivery among blacks or African Americans — 61 health department jurisdictions, United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(4):87–90.

    PubMed  PubMed Central  Google Scholar 

  22. Krueger A, Dietz P, Van Handel M, Belcher L, et al. Estimates of CDC-funded and national HIV diagnoses: a comparison by demographic and HIV-related factors. AIDS Behav. 2016;20:2961–5.

    PubMed  Google Scholar 

  23. Mustanski B, Morgan E, D’Aquila R, Birkett M, et al. Individual and network factors associated with racial disparities in HIV among young men who have sex with men: results from the Radar Cohort Study. J Acquir Immune Defic Syndr. 2018; https://doi.org/10.1097/QAI.0000000000001886. [Epub ahead of print].

  24. Van Handel M, Kann L, Olsen EO, Dietz P. HIV testing among US high school students and young adults. Pediatrics. 2016;137(2):e20152700.

    PubMed  Google Scholar 

  25. Ford CL, Mulatu MS, Godette DC, Gaines TL. Trends in HIV testing among U.S. older adults prior to and since release of CDC’s routine HIV testing recommendations: National Findings from the BRFSS. Public Health Rep. 2015;130:514–25.

    PubMed  PubMed Central  Google Scholar 

  26. Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV infection in transgender adults and adolescents: results from the National HIV Surveillance System, 2009–2014. AIDS Behav. 2017;21:2774–83.

    PubMed  PubMed Central  Google Scholar 

  27. Eldred L, Malitz F. Introduction to the supplemental issue on the HRSA SPNS outreach initiative. AIDS Patient Care STDS. 2007;21(Suppl 1):S1–2.

    Google Scholar 

  28. Gardner EM, McLees MP, Steiner JE, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. CID. 2011;52:793–800.

    Google Scholar 

  29. Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, et al. Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial. J Acquir Immune Defic Syndr. 2017;74(1):112–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5(6):e11068.

    PubMed  PubMed Central  Google Scholar 

  31. Montaner JSG, Lima VC, Harrigan PR, Lourenc L, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS One. 2014;9(2):e87872.

    PubMed  PubMed Central  Google Scholar 

  32. Sheehan DM, Fennie KP, Mauck DE, Maddox L, et al. Retention in HIV care and viral suppression: individual- and Neighborhood-level predictors of racial/ethnic differences, Florida, 2015. AIDS Patient Care STDs. 2017;31(4):167–75.

    PubMed  PubMed Central  Google Scholar 

  33. Giordano TP. The HIV treatment cascade – a new tool in HIV prevention. JAMA Intern Med. 2015;175(4):596–7. https://doi.org/10.1001/jamainternmed.2014.8199.

    Article  PubMed  Google Scholar 

  34. Bradley H, Hall I, Wolitski RJ, Van Handel MM, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV — United States, 2011. MMWR. 2014;63(47):1113–7.

    PubMed  PubMed Central  Google Scholar 

  35. Skarbinski J, Rosenberg E, Paz-Bailey G, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.

    PubMed  Google Scholar 

  36. Hull M, Montaner J. Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy. Curr HIV/AIDS Rep. 2011;8:85–93.

    PubMed  Google Scholar 

  37. Whiteside YO, Cohen SM, Bradley H, Skarbinski J, et al. Progress along the continuum of HIV care among blacks with diagnosed HIV – United States 2010. MMWR. 2014;63(5):85–9.

    PubMed  PubMed Central  Google Scholar 

  38. Hightow-Weidman L, LeGrand S, Choi SK, Egger J, et al. Exploring the HIV continuum of care among young black MSM. PLoS One. 2017;12(6):e0179688.

    PubMed  PubMed Central  Google Scholar 

  39. Whitmore SK, Kann L, Prejean J, Koenig LJ, et al. Vital signs: HIV infection, testing, and risk behaviors among youths — United States. MMWR. 2012;61(47):971–6.

    Google Scholar 

  40. Kann L, McManus KL, Harris WA, Shanklin SL, Flint KH, Queen B, et al. Youth risk behavior surveillance – United States, 2017. MMWR Surveill Summ. 2018;67(8):1–114.

    PubMed  PubMed Central  Google Scholar 

  41. Camacho-Gonzalez AF, Gillespie SE, Thomas-Seaton L, Frieson K, et al. The Metropolitan Atlanta community adolescent rapid testing initiative study: closing the gaps in HIV care among youth in Atlanta, Georgia, USA. AIDS. 2017;31(Suppl 3):S267–75.

    PubMed  Google Scholar 

  42. Murray A, Hussen SA, Toledo L, Thomas-Seaton L, Gillespie S. Optimizing community-based HIV testing and linkage to care for young persons in Metropolitan Atlanta. AIDS Patient Care STDs. 2018;32(6):234–40.

    PubMed  Google Scholar 

  43. Kaiser Permanente Research Brief – HIV/AIDS. 2018. https://share.kaiserpermanente.org/wp-content/uploads/2018/07/research_brief_hiv_aids_20180709.pdf.

  44. Hornberg MA, Hurley LB, Klein DB, Towner WJ, et al. The HIV care cascade measured over time and by age, sex, and race in a large national integrated care system. AIDS Patient Care STDs. 2015;29(11):582–90.

    Google Scholar 

  45. Gantt Z, Dailey A, Hu X, Satcher-Johnson A. HIV care outcomes among Hispanics or Latinos with diagnosed HIV infection — United States, 2015. MMWR. 2017;66(40):1065–72.

    Google Scholar 

  46. Baral SD, Poteat T, Stromdahl S, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22.. https://doi.org/10.1016/S1473-3099(12)70315-8

    PubMed  Google Scholar 

  47. Denson DJ, Padgett PM, Pitts N, Paz-Bailey G, et al. Health care use and HIV-related Behaviors of black and Latina transgender women in 3 US Metropolitan areas: results from the transgender HIV behavioral survey. J Acquir Immune Defic Syndr. 2017;75:S268–75.

    PubMed  PubMed Central  Google Scholar 

  48. Sevelius J, Carrico A, Johnson M. Antiretroviral therapy adherence among transgender women. J Assoc Nurses AIDS Care. 2010;21(3):256–64. https://doi.org/10.1016/j.jana.2010.01.005.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Melendez R, Exner T, Ehrhardt A, et al. Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health. 2005;95:5–7.

    Google Scholar 

  50. Sevelius JM, Patouhas E, Keatley JG, Mallory O, et al. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16. https://doi.org/10.1007/s12160-013-9565-8.

    Article  PubMed  Google Scholar 

  51. Iroh PA, Mao H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–e16.

    PubMed  PubMed Central  Google Scholar 

  52. Loeliger KB, Altice FL, Ciarleglio MM, Rich KM, et al. All-cause mortality among people with HIV released from an integrated system of jails and prisons in Connecticut, USA, 2007-14: a retrospective observational cohort study. Lancet HIV. 2017; https://doi.org/10.1016/S2352-3018(18)30175-9.

  53. Wohl DA, Rosen DL. Inadequate HIV care after incarceration: case closed. Lancet HIV. 2018;5(2):e64–5.

    PubMed  Google Scholar 

  54. Bogart LM, et al. Medical mistrust among social network members may contribute to antiretroviral treatment nonadherence in African Americans living with HIV. Soc Sci Med. 2016;164:133–40.

    PubMed  PubMed Central  Google Scholar 

  55. Hoenigl M, et al. Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Sci Rep. 2016;6:2947.

    Google Scholar 

  56. Koenig SP, et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial. PLoS Med. 2017;14(7):e1002357.

    PubMed  PubMed Central  Google Scholar 

  57. Mugavero MJ, Amico KR, Horn T, Thompson MA. The state of engagement in HIV care in the United States: from cascade to continuum to control. CID. 2013;57(8):1164–71.

    Google Scholar 

  58. Robertson MK, et al. Linkage and retention in care and the time to HIV viral suppression and viral rebound–New York City. AIDS Care. 2015;27(2):260–7.

    PubMed  Google Scholar 

  59. Dailey AF, Satcher Johnson A, Wu B. HIV care outcomes among blacks with diagnosed HIV — United States, 2014. MMWR Morb Mortal Wkly Rep. 2017;66(4):97–103.

    PubMed  PubMed Central  Google Scholar 

  60. Centers for Disease Control and Prevention. Social determinants of health among adults with diagnosed HIV infection, 2016. Part B: county-level social determinants of health and selected care outcomes among adults with diagnosed HIV infection—39 states and the District of Columbia. HIV Surveillance Supplemental Report. 2018;23(No. 6, pt B). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published October 2018.

  61. Centers for Disease Control and Prevention. Social determinants of health and selected HIV care outcomes among adults with diagnosed HIV infection in 37 states and the District of Columbia, 2015. HIV Surveillance Supplemental Report. 2017;22(4). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

  62. Storholm ED, Bogart LM, Mutchler MG, Klein DJ, et al. Antiretroviral adherence trajectories among black Americans living with HIV. AIDS Behav. 2018; https://doi.org/10.1007/s10461-018-2303-2. [Epub ahead of print].

  63. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med. 2008;168:1181–7.

    PubMed  Google Scholar 

  64. Hightow-Weidman LB, Jones K, Wohl AR, et al. Early linkage and retention in care: findings from the outreach, linkage, and retention in care initiative among young men of color who have sex with men. AIDS Patient Care STDs. 2011;25(suppl 1):S31–8.

    PubMed  Google Scholar 

  65. Bauman LJ, Braunstein S, Calderon Y, Chhabra R, et al. Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr (1999). 2013;64(0 1):S20–6.

    Google Scholar 

  66. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, Del Rio C, Strathdee S, Sansom SL, Siegal HA, Greenberg AE, Holmberg SD. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19(4):423–31.

    PubMed  Google Scholar 

  67. Craw JA, Gardner LI, Marks G, et al. ARTAS II: brief strengths-based case management promotes entry into HIV medical care: results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr. 2008;47:597–606.

    CAS  PubMed  Google Scholar 

  68. Gardner LI, Marks G, Craw J, Metsch L, Strathdee S, Anderson-Mahoney P, del Rio C. Demographic, psychological, and behavioral modifiers of the antiretroviral treatment access study (ARTAS) intervention. AIDS Patient Care STDs. 2009;23(9):735–42.

    PubMed  Google Scholar 

  69. Parnell H, Berger M, Gichance M, et al. Lost to care and back again: patient and navigator perspectives on HIV care re-engagement. AIDS Behav. 2017; https://doi.org/10.1007/s10461-017-1919-y.

  70. Rajabiun S, Cabral H, Tobias C, Relf M. Program design and evaluation strategies for the Special Projects of National Significance Outreach Initiative. AIDS Patient Care STDs. 2007;21(S1):1–9.

    Google Scholar 

  71. Liau A, Crepaz N, Lyles CM, Higa DH, Mullins MM, DeLuca J, Petters S, Marks G. Interventions to promote linkage to and utilization of HIV medical care among HIV-diagnosed persons: a qualitative systematic review, 1996–2011. AIDS Behav. 2013;17(6):1941–62.

    PubMed  PubMed Central  Google Scholar 

  72. Anderson RM, Bozzette SM, Shapiro MR, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the U.S. Health Serv Res. 2000;35(2):389–416.

    Google Scholar 

  73. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38(1):96–103.

    PubMed  Google Scholar 

  74. Cunningham WE, Mardson LW, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr. 2000;25(2):115–23.

    CAS  PubMed  Google Scholar 

  75. Beer L, Bradley H, Mattson CL, Johnson CH, et al. Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009-2013. J Acquir Immune Defic Syndr. 2016;73(4):446–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Landovitz RJ, Desmond KA, Leibowitz AA. Antiretroviral therapy: racial disparities among publicly insured Californians with HIV. J Health Care Poor Underserved. 2017;28(1):406–29.

    PubMed  PubMed Central  Google Scholar 

  77. Desir FA, Lesko CR, Moore RD, Horberg MA, et al. One size fits (n)one: the influence of sex, age, and sexual human immunodeficiency virus (HIV) acquisition risk on racial/ethnic disparities in the HIV care continuum in the United States. CID. 2018; https://doi.org/10.1093/cid/ciy556.

  78. Neumann MS, Plant A, Margolis AD, Borkowf CB, et al. Effects of a brief video intervention on treatment initiation and adherence among patients attending human immunodeficiency virus treatment clinics. PLoS One. 2018;13(10):e0204599. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0204599#references.

    PubMed  PubMed Central  Google Scholar 

  79. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, et al. The effect of same-day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting. J Acquir Immune Defic Syndr. 2017;74(1):44–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Branson BM, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morb Mortal Wkly Rep Recomm Rep. 2006;55(14):1–17.

    Google Scholar 

  81. Rebeiro PF, Gange SJ, Horberg MA, Abraham AG, Napravnik S, Samji H, Yehia BR, Althoff KN, Moore RD, Kitahata MM, Sterling TR. Geographic variations in retention in care among HIV-infected adults in the United States. PLoS One. 2016;11(1):e0146119.

    PubMed  PubMed Central  Google Scholar 

  82. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T. 2014. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Rodger A, Bruun T, Cambiano V, Vernazza P, et al. HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. 21st Conference on retroviruses and opportunistic infections, 3–6 March 2014. Boston; 2014.

    Google Scholar 

  84. Grulich AE, Bavinton BR, Jin F, Prestage G, et al. HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil [Poster Number 1019LB]. 22nd Conference on retroviruses and opportunistic infections. Seattle;, 2015.

    Google Scholar 

  85. Breskin A, Adimora A, Westreich D. Women and HIV in the United States. PLoS One. 2017;12(2):e0172367.

    PubMed  PubMed Central  Google Scholar 

  86. Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14:493–503.

    PubMed  Google Scholar 

  87. Cantrell RA, Sinkala M, Megazinni K, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49:190–5.

    PubMed  Google Scholar 

  88. Andersen M, Hockman E, Smereck G, et al. Retaining women in HIV medical care. J Assoc Nurses AIDS Care. 2007;18:33.

    PubMed  Google Scholar 

  89. Lipira L, Williams EC, Huh D, Kemp C, et al. HIV-related stigma and viral suppression among African-American women: exploring the mediating roles of depression and ART nonadherence. AIDS Behav. 2018 Oct 20; https://doi.org/10.1007/s10461-018-2301-4. [Epub ahead of print].

  90. Hartzler B, Dombrowski JC, Williams JR, Crane HM, Eron JJ, Geng EH, Mathews C, Mayer KH, Moore RD, Mugavero MJ, Napravnik S. Influence of substance use disorders on 2-year HIV care retention in the United States. AIDS Behav. 2018;22(3):742–51.

    PubMed  PubMed Central  Google Scholar 

  91. Mustanski B, Garofalo R, Herrick A, Donenberg G. Psychosocial health problems increase risk for HIV among urban young men who have sex with men: preliminary evidence of a syndemic in need of attention. Ann Behav Med. 2007;34(1):37–45.

    PubMed  Google Scholar 

  92. Sullivan KA, Messer LC, Quiinlivan EB. Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color. AIDS Patient Care STDs. 2015;9(S1):S42–8.

    Google Scholar 

  93. Gardner LI, Marks G, Craw JA, Wilson TE, et al. A low-effort, clinic-wide intervention improves attendance for HIV primary care. CID. 2012;55(8):1124–34. https://doi.org/10.1093/cid/cis623.

    Article  Google Scholar 

  94. Gardner LI, Giordano TP, Marks G, Wilson TE, Craw JA, Drainoni ML, Keruly JC, Rodriguez AE, Malitz F, Moore RD, Bradley-Springer LA. Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics. CID. 2014;59(5):725–34.

    Google Scholar 

  95. Beach MC, Keruly J, Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? JGIM. 2006;21(6):661–5. https://doi.org/10.1111/j.1525-1497.2006.00399.x.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Langebeek N, Gisolf EH, Reiss P, Vervoort SC, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142.

    PubMed  PubMed Central  Google Scholar 

  97. Bogart LM, Wagner G, Galvan FH. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr. 2010;53(5):648–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Levison JH, et al. “Where it falls apart”: barriers to retention in HIV care in Latino immigrants and migrants. AIDS Patient Care STDs. 2017;31(9):394–405.

    PubMed  PubMed Central  Google Scholar 

  99. Buchanan D, Kee R, Sadowsi LS. Garcia. The health impact of supportive housing for HIV positive homeless patients: a randomized control trial. Am J Public Health. 2009;99(Suppl 3):S675–80.

    PubMed  PubMed Central  Google Scholar 

  100. Bradford JB, Coleman S, Cunningham W. HIV system navigation: an emerging model to improve HIV care access. AIDS Patient Care STDs. 2007;21(suppl 1):S49–58.

    PubMed  Google Scholar 

  101. Cunningham WE, et al. Effects of a laboratory health information exchange intervention on antiretroviral therapy use, viral suppression, and racial/ethnic disparities. JAIDS. 2017;75(3):290–8.

    PubMed  Google Scholar 

  102. Lall P, Lim SH, Khairuddin N, Kamarulzaman A. An urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations. J Int AIDS Soc. 2017;18:19393.

    Google Scholar 

  103. Hightow-Weidman LB, Justin C, Smith EV, Matthews D, et al. Keeping them in “STYLE”: finding, linking, and retaining young HIV-positive black and Latino men who have sex with men in care. AIDS Patient Care STDs. 2011;25(1):37–45.

    PubMed  PubMed Central  Google Scholar 

  104. Magnus M, Jones K, Phillips G, Binson HW, et al. Characteristics associated with retention among African American and Latino adolescent HIV-positive men: results from the outreach, care, and prevention to engage HIV-seropositive young MSM of color special project of National Significance Initiative. JAIDS J Acquir Immune Defic Syndr. 2010;53(4):529–36.

    PubMed  Google Scholar 

  105. Koblin B, Hirshfield S, Chaisson MA, Wilton L, et al. Intervention to match young black men and transwomen who have sex with men or transwomen to HIV testing options (all about me): protocol for a randomized controlled trial. JMIR Res Protoc. 2017;6(12):e254.

    PubMed  PubMed Central  Google Scholar 

  106. Hoots BE, Finlayson TJ, Wejnert C, Paz-Bailey G, NHBS Study Group. Updated data on linkage to HIV care and antiretroviral treatment among men who have sex with men—20 cities, United States. J Infect Dis. 2017;216:808–12.

    PubMed  Google Scholar 

  107. Vermund SH. The continuum of HIV Care in the Urban United States: black men who have sex with men (MSM) are less likely than white MSM to receive antiretroviral therapy. J Infect Dis. 2017;216(7):790–4.

    PubMed  PubMed Central  Google Scholar 

  108. Herbst JH, Mansergh PN, Denson D, et al. Effects of brief messages about antiretroviral therapy and condom use benefits among black and Latino MSM in three U.S. cities. J Homosex. 2018;65(2):154–66.

    PubMed  Google Scholar 

  109. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014;26(8):976–82.

    PubMed  PubMed Central  Google Scholar 

  110. Sevelius JM, Patouhas E, Keatley JG, Johnson MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med. 2014;47(1):5–16.

    PubMed  Google Scholar 

  111. Rebchook G, Keatley J, Contreras R, Perloff J, Molano LF, Reback CJ, et al. The transgender women of color initiative: implementing and evaluating innovative interventions to enhance engagement and retention in HIV care. Am J Public Health. 2017;107(2):224–9.

    PubMed  PubMed Central  Google Scholar 

  112. Centers for Disease Control and Prevention. HIV among youth. https://www.cdc.gov/hiv/group/age/youth/index.html. Last accessed 28 Oct 2018.

  113. Agwu AL, Fairlie L. Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc. 2013;16:18579.

    PubMed  PubMed Central  Google Scholar 

  114. Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press; 2004.

    Google Scholar 

  115. Blanton RE, Levitt JG, Thompson PM, Narr KL, Capetillo-Cunliffe L, Nobel A, et al. Mapping cortical asymmetry and complexity patterns in normal children. Psychiatry Res Neuroimaging. 2001;107(1):29–43.

    CAS  Google Scholar 

  116. Toga AW, Thompson PM, Sowell ER. Mapping brain maturation. Trends Neurosci. 2006;29(3):148–59.

    CAS  PubMed  PubMed Central  Google Scholar 

  117. Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.

    CAS  PubMed  PubMed Central  Google Scholar 

  118. Millett GA, Peterson JL, Flores SA, Hart TA, Jeffries WL, Wilson PA, et al. Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis. Lancet. 2012;380(9839):341–8.

    PubMed  Google Scholar 

  119. Lee L, Yehia BR, Gaur AH, Rutstein R, Gebo K, Keruly JC, et al. The impact of youth-friendly structures of care on retention among HIV-infected youth. AIDS Patient Care STDs. 2016;30(4):170–7.

    PubMed  PubMed Central  Google Scholar 

  120. Fortenberry JD, Koenig LJ, Kapogiannis BG, Jeffries CL, Ellen JM, Wilson CM. Implementation of an integrated approach to the national HIV/AIDS strategy for improving human immunodeficiency virus care for youths. JAMA Pediatr. 2017;171(7):687–93.

    PubMed  Google Scholar 

  121. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 29 Mar 2018.

  122. Cervia JS. Easing the transition of HIV-infected adolescents to adult care. AIDS Patient Care STDs. 2013;27(12):692–6.

    PubMed  PubMed Central  Google Scholar 

  123. Dowshen N, D'Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128(4):762–71.

    PubMed  Google Scholar 

  124. Mitsch AJ, Hall HI, Babu AS. Trends in HIV infection among persons who inject drugs: United States and Puerto Rico, 2008–2013. Am J Public Health. 2016;106(12):2194–201.

    PubMed  PubMed Central  Google Scholar 

  125. Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health. 2007;97(1):125–32.

    PubMed  PubMed Central  Google Scholar 

  126. Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs – 20 cities, United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(1):23–8.

    PubMed  PubMed Central  Google Scholar 

  127. Des Jarlais DC, Bramson HA, Wong C, Gostnell K, Cepeda J, Arasteh K, et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction. 2012;107(12):2087–95.

    PubMed  PubMed Central  Google Scholar 

  128. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74.

    PubMed  Google Scholar 

  129. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376(9738):355–66.

    PubMed  Google Scholar 

  130. Milloy MJ, Kerr T, Bangsberg DR, Buxton J, Parashar S, Guillemi S, et al. Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care STDs. 2012;26(1):60–7.

    PubMed  PubMed Central  Google Scholar 

  131. Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.

    PubMed  Google Scholar 

  132. Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, et al. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet. 2018;392(10149):747–59.

    PubMed  PubMed Central  Google Scholar 

  133. Wildeman C, Wang EA. Mass incarceration, public health, and widening inequality in the USA. Lancet. 2017;389(10077):1464–74.

    PubMed  Google Scholar 

  134. Substance Abuse and Mental Health Services Administration. Summary of the effects of the 2015 National Survey on drug use and health questionnaire redesign: implications for data users. CBHSQ Methodology Report. Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2016.

    Google Scholar 

  135. Eversman MH, Bird JD. Moral panic and social justice: a guide for Analyzing social problems. Soc Work. 2017;62(1):29–36.

    PubMed  Google Scholar 

  136. Costa M, Montague BT, Solomon L, Sammartino C, Gutman R, Zibman C, et al. Assessing the effect of recent incarceration in prison on HIV care retention and viral suppression in two states. J Urban Health. 2018;95(4):499–507.

    PubMed  PubMed Central  Google Scholar 

  137. Centers for Disease Prevention and Control. HIV among incarcerated populations. http://www.cdc.gov/hiv/group/correctional.html. Accessed: 1 June 2016.

  138. Iroh PA, Mayo H, Nijhawan AE. The HIV care cascade before, during, and after incarceration: a systematic review and data synthesis. Am J Public Health. 2015;105(7):e5–16.

    PubMed  PubMed Central  Google Scholar 

  139. Erickson M, Shannon K, Sernick A, Pick N, Ranville F, Martin RE, et al. Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories. AIDS. 2019;33(1):101–11.

    PubMed  Google Scholar 

  140. Cunningham WE, Weiss RE, Nakazono T, Malek MA, Shoptaw SJ, Ettner SL, et al. Effectiveness of a peer navigation intervention to sustain viral suppression among HIV-positive men and transgender women released from jail: the LINK LA randomized clinical trial. JAMA Intern Med. 2018;178(4):542–53.

    PubMed  PubMed Central  Google Scholar 

  141. CDC. CDC fact sheet: HIV among women. 2014. http://www.cdc.gov/hiv/risk/gender/women. Last accessed Feb 2015.

  142. CDC. CDC fact sheet: new HIV infections in the United States. 2016. https://www.cdc.gov/nchhstp/newsroom/docs/factsheets/new-hiv-infections-508.pdf. Last accessed Feb 2018.

  143. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52.

    PubMed  Google Scholar 

  144. Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression. Clin Infect Dis. 2015;61(12):1880–7.

    PubMed  Google Scholar 

  145. Taylor AW, Nesheim SR, Zhang X, Song R, FitzHarris LF, Lampe MA, et al. Estimated perinatal HIV infection among infants born in the United States, 2002–2013. JAMA Pediatr. 2017;171(5):435–42.

    PubMed  PubMed Central  Google Scholar 

  146. Rana AI, Gillani FS, Flanigan TP, Nash BT, Beckwith CG. Follow-up care among HIV-infected pregnant women in Mississippi. J Women's Health. 2010;19(10):1863–7.

    Google Scholar 

  147. Meade CM, Badell M, Hackett S,Mehta CC, Haddad LB, Camacho-Gonzalez A, Ford J, Hostad MM, Armstrong WS and Sheth AN. HIV Care Continuum Among Post Partum Women Living in Atlanta. Infect Dis Obstet Gynecol. 2019;2019:8161495. Published 2019 Feb 14. https://doi.org/10.1155/2019/8161495.

  148. Rana A JK, Lanier C, Nash B, Zlotnick C, Wingood G, Mena L, Konkle-Parker D, Wilson I. High mortality among HIV-infected women following delivery in Mississippi. In: 12th International conference on HIV treatment and prevention adherence. Miami; 2017.

    Google Scholar 

  149. Rana AI JK, Lanier C, Nash B, Zlotnick C, Wingood G, Mena L, Konkle-Parker D, Wilson IB. High mortality and low rates of long term engagement in care following delivery among HIV infected women in Mississippi (oral presentation). In: 11th International conference on HIV treatment and prevention adherence. Ft. Lauderdale; 2016.

    Google Scholar 

  150. The National HIV/AIDS Response Overview. https://www.hiv.gov/federal-response/national-hiv-aids-strategy/overview. Last accessed 1 Nov 2018.

  151. Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.

    PubMed  PubMed Central  Google Scholar 

  152. Johnsen LE, Thimm MA, Singer JM, Page KR. P2.24 Awareness and interest in pre-exposure prophylaxis (PREP) among patients receiving services at a public sexually transmitted diseases (STD) clinic in a high prevalence urban setting. Sex Trans Infect. 2017;93(Suppl 2):A79.72–A79.

    Google Scholar 

  153. Chapman Lambert C, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing women to prevent HIV: an integrated theoretical framework to PrEP black women in the United States. J Assoc Nurses AIDS Care. 2018;29(6):835–48.

    PubMed  Google Scholar 

  154. Gwadz M, Cleland CM, Kutnick A, Leonard NR, Ritchie AS, Lynch L, et al. Factors associated with recent HIV testing among heterosexuals at high risk for HIV infection in New York City. Front Public Health. 2016;4:76.

    PubMed  PubMed Central  Google Scholar 

  155. Levy ME, Wilton L, Phillips G 2nd, Glick SN, Kuo I, Brewer RA, et al. Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States. AIDS Behav. 2014;18(5):972–96.

    PubMed  PubMed Central  Google Scholar 

  156. Yehia BR, Stewart L, Momplaisir F, Mody A, Holtzman CW, Jacobs LM, et al. Barriers and facilitators to patient retention in HIV care. BMC Infect Dis. 2015;15:246.

    PubMed  PubMed Central  Google Scholar 

  157. Centers for Disease Control and Prevention. Social determinants of health and selected HIV care outcomes among adults with diagnosed HIV infection in 37 states and the District of Columbia, 2015. HIV Surveillance Supplemental Report. 2017;22(No. 4). http://wwwcdcgov/hiv/library/reports/hiv-surveillancehtml. Published October 2017. Accessed 22 Oct 2018.

  158. Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493–503.

    PubMed  Google Scholar 

  159. Desir FA, Lesko CR, Moore RD, Horberg MA, Wong C, Crane HM, et al. One size fits (n)one: the influence of sex, age, and sexual human immunodeficiency virus (HIV) acquisition risk on racial/ethnic disparities in the HIV care continuum in the United States. Clin Infect Dis. 2019;68(5):795–802.

    CAS  PubMed  Google Scholar 

  160. Tabler J, Mykyta L, Schmitz RM, Kamimura A, Martinez DA, Martinez RD, et al. Social determinants of sexual behavior and awareness of sexually transmitted infections (STI) among low-income HIV+ or STI at-risk hispanic residents receiving care at the U.S.-Mexico Border. J Community Health. 2019;44(1):127–36.

    PubMed  Google Scholar 

  161. Garrido M, Sufrinko N, Max J, Cortes N. Where youth live, learn, and play matters: tackling the social determinants of health in adolescent sexual and reproductive health. Am J Sex Educ. 2018;13(1):1–14.

    Google Scholar 

  162. Howland R, Angley M, Won SH, Searing H, Wilcox W. A population-based study of severe maternal morbidity in New York City, 2008–2012 [30C]. Obstet Gynecol. 2016;127:34S.

    Google Scholar 

  163. Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197–209.

    PubMed  PubMed Central  Google Scholar 

  164. De Cock KM, Simone PM, Davison V, Slutsker L. The new global health. Emerg Infect Dis. 2013;19(8):1192–7.

    PubMed  PubMed Central  Google Scholar 

  165. Poteat T, Wirtz AL, Radix A, Borquez A, Silva-Santisteban A, Deutsch MB, et al. HIV risk and preventive interventions in transgender women sex workers. Lancet. 2015;385(9964):274–86.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HIV/STD Services and Community Risk Reduction, Baltimore City Health Department, Baltimore, MA, USA

    Victoria A. Cargill

  2. Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Florence M. Momplaisir

Authors
  1. Victoria A. Cargill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Florence M. Momplaisir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Victoria A. Cargill .

Editor information

Editors and Affiliations

  1. Division of Global Health Equity, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USA

    Bisola O. Ojikutu

  2. Division of General Internal Medicine, Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital Harvard Medical School, Boston, MA, USA

    Valerie E. Stone

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cargill, V.A., Momplaisir, F.M. (2021). Epidemiology of HIV Infection in Communities of Color in the United States. In: Ojikutu, B., Stone, V. (eds) HIV in US Communities of Color. Springer, Cham. https://doi.org/10.1007/978-3-030-48744-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48744-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48743-0

  • Online ISBN: 978-3-030-48744-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation